Home > Formulary : Adult > Recent Decisions > 2024 >
Decisions 21st May
New Drug Requests:
- Hexaminolevulinate (Hexvix) (TLS Red) for use in patients with high or very high risk non-muscle invasive bladder cancer to aid improved visualisation of bladder cancer
- Bleomycin (IV) in combination with reversible electroporation of the spinal tumour as an electrochemotherapy treatment (TLS Red) for treatment of metastatic spinal cord compression
- Drospirenone (Slynd) (TLS Blue) second line progesterone only pill
- Ethinylestradiol / drospirenone (Yacella and Dretine) (TLS Blue) second line combined hormonal contraceptive
- Ethinylestradiol / gestodene (Millinette 30/75 and 20/75) (TLS Blue) second line combined hormonal contraceptive. Femodene ED brand also approved for use where the inactive tablets may add benefit to support compliance only.
- Doublebase Once gel (TLS Blue) as a second line emollient option for chronic severe inflammatory hand conditions where first line emollient options have not controlled disease.
- Adex gel (TLS Blue) as a second line emollient option for facial inflammatory conditions - eczema, psoriasis, perioral dermatitis, seborrhoeic dermatitis. For use in patients with facial inflammatory conditions where topical steroid sparing is required but topical calcineurin inhibitors are not tolerated/effective or reduced topical corticosteroid frequencies are giving flare and alternative options have not controlled disease.
Shared Care Protocols:
- Dapsone SCP updated
- Sodium valproate SCP updated
Traffic light status changes:
- Sodium clodronate for myeloma – TLS changed to Red and Clasteon brand added
- Cylophosphamide - TLS changed to Red on every formulary page, reference to TLS Amber for non-malignancy removed.
Other decisions and discussions:
- Sodium clodronate for osteoporosis, corticosteroid induced osteoporosis and Paget’s to be removed from Formulary as no longer used.
- Nutrizym 22 pancreatic enzyme approved for inclusion onto Joint Formulary as TLS Blue
- Canesten HC cream approved for use as an alternative to Daktacort cream as TLS Green
- Spironolactone for acne in female patients was discussed. This requires further work before inclusion on the Joint Formulary.
- Klean-Prep discontinued and removed from the Joint Formulary.
- Miconazole pessary discontinued and removed the Joint Formulary.
- Tresiba U200 for use on renal dialysis unit – removed from specialist populations section of Chapter 6.3 on Joint Formulary as no longer required.